Kids Library Home

Welcome to the Kids' Library!

Search for books, movies, music, magazines, and more.

Extended Display Limit/Sort Search
     
Available items only
Result Page   
Add Marked to Bag Add All On Page
Num Mark Titles (201-250 of 337) Year Entries
371 Found
201 Guidance for industry [electronic resource] : pharmacovigilance of veterinary medicinal products, ma   2006 1
202 Guidance for industry [electronic resource] : pharmacovigilance of veterinary medicinal products : m   2001 1
203 Guidance for industry [electronic resource] : photosafety testing.   2003 1
204 Guidance for industry [electronic resource] : population pharmacokinetics.   1999 1
205 Guidance for industry [electronic resource] : possible dioxin/PCB contamination of drug and biologic   1999 1
206 Guidance for industry [electronic resource] : potassium chloride modified-release tablets and capsul   2005 1
207 Guidance for industry [electronic resource] : potency tests for cellular and gene therapy products.   2008 1
208 Guidance for industry [electronic resource] : pre-approval information for registration of new veter   2004 1
209 Guidance for industry [electronic resource] : pre-storage leukocyte reduction of whole blood and blo   2001 1
210 Guidance for industry [electronic resource] : precautionary measures to reduce the possible risk of   2
211 Guidance for industry [electronic resource] : premarketing risk assessment.   2005 1
212 Guidance for industry [electronic resource] : preparation of IDEs and INDs for products intended to   2007 1
213 Guidance for industry [electronic resource] : Prescription Drug Marketing Act, donation of prescript   2006 1
214 Guidance for industry [electronic resource] : Prescription Drug Marketing Act (PDMA) requirements, q   2006 1
215 Guidance for industry [electronic resource] : presenting risk information in prescription drug and m   2009 1
216 Guidance for industry [electronic resource] : process validation, general principles and practices.   2008 1
217 Guidance for industry [electronic resource] : protecting the rights, safety and welfare of study sub   2007 1
218 Guidance for industry [electronic resource] : providing clinical evidence of effectiveness for human   1998 1
219 Guidance for industry [electronic resource] : providing regulatory submissions in electronic format,   2005 1
220 Guidance for industry [electronic resource] : providing regulatory submissions in electronic format,   2
221 Guidance for industry [electronic resource] : providing regulatory submissions in electronic format,   2003 1
222 Guidance for industry [electronic resource] : providing regulatory submissions in electronic format   2
223 Guidance for industry [electronic resource] : providing regulatory submissions in electronic format,   2008 1
224 Guidance for industry [electronic resource] : providing regulatory submissions in electronic format,   2001 1
225 Guidance for industry [electronic resource] : providing regulatory submissions in electronic format,   2007 1
226 Guidance for industry [electronic resource] : providing regulatory submissions to CBER in electronic   2002 1
227 Guidance for industry [electronic resource] : providing regulatory submissions to the Center for Bio   2007 1
228 Guidance for industry [electronic resource] : public health issues posed by the use of nonhuman prim   1999 1
229 Guidance for industry [electronic resource] : Q10 pharmaceutical quality system.   2009 1
230 Guidance for industry [electronic resource] : Q1A(R2) stability testing of new drug substances and p   2003 1
231 Guidance for industry [electronic resource] : Q1B photostability testing of new drug substances and   1996 1
232 Guidance for industry [electronic resource] : Q1C stability testing for new dosage forms.   1996 1
233 Guidance for industry [electronic resource] : Q1D bracketing and matrixing designs for stability tes   2003 1
234 Guidance for industry [electronic resource] : Q1E evaluation of stability data.   2004 1
235 Guidance for industry [electronic resource] : Q2B validation of analytical procedures, methodology.   1996 1
236 Guidance for industry [electronic resource] : Q3A impurities in new drug substances.   2
237 Guidance for industry [electronic resource] : Q3B(R2) impurities in new drug products.   2006 1
238 Guidance for industry [electronic resource] : Q3C impurities, residual solvents.   1997 1
239 Guidance for industry [electronic resource] : Q3C tables and list.   2003 1
240 Guidance for industry [electronic resource] : Q4B evaluation and recommendation of pharmacopoeial te   9
241 Guidance for industry [electronic resource] : Q4B evaluation and recommendation of pharmocopoeial te   2009 1
242 Guidance for industry [electronic resource] : Q5A viral safety evaluation of biotechnology products   1998 1
243 Guidance for industry [electronic resource] : Q5E comparability of biotechnological/biological produ   2005 1
244 Guidance for industry [electronic resource] : Q6B specifications : test procedures and acceptance cr   1999 1
245 Guidance for industry [electronic resource] : Q7A good manufacturing practice guidance for active ph   2001 1
246 Guidance for industry [electronic resource] : Q8 pharmaceutical development.   2006 1
247 Guidance for industry [electronic resource] : Q8(R2) pharmaceutical development.   2009 1
248 Guidance for industry [electronic resource] : Q9 quality risk management.   2006 1
249 Guidance for industry [electronic resource] : qualifying for pediatric exclusivity under section 505   1999 1
250 Guidance for industry [electronic resource] : quality systems approach to pharmaceutical CGMP regula   2006 1
Add Marked to Bag Add All On Page
Locate in results
Result Page   
Extended Display Limit/Sort Search
 
    
Available items only